Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

New treatment targets identified in opiate abstinence

Nov. 3, 2021

RM-1490, a novel MOR agonist as maintenance therapeutic in opioid use disorder

Nov. 2, 2021

Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury

Oct. 8, 2021

New 5-HT2 receptor agonists identified

Oct. 6, 2021

NIDA agrees to screen Initiator Pharma's preclinical assets for anti-addictive properties

Sep. 20, 2021

MC-100093 attenuates cocaine relapse in rats

Sep. 16, 2021

LB-100 blocks METH-induced drug-seeking/taking behavior in mice

Sep. 8, 2021

Camino studies SBP-9330 in first-in-human trial for smoking cessation

Aug. 26, 2021

FDA clears IND application for DCR-AUD

July 30, 2021

Opiant reports topline data from confirmatory PK study of OPNT-003 for opioid overdose

July 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...